Please select the eligibility criteria that correspond to the clinical trial below.
Title: Increased Access to Emergency Contraceptive Pills
Brief Summary: This study will evaluate the effect of easy access to emergency contraceptive pills (ECPs) on the rates of pregnancy and sexually transmitted infections (STIs).


Options:
A: Inclusion Criteria

* Sexual intercourse with a male partner at least twice in the month prior to study entry
* Does not desire pregnancy within 1 year of study entry
* 6 weeks since the end of her last pregnancy and has had at least one menstrual period since resolution of her last pregnancy
* Literate in English or Spanish

Exclusion Criteria

* Surgically sterilized or intends to become sterilized within 1 year of study entry
* Intrauterine device or a hormonal implant in place or intends to have one inserted within 1 year of study entry
* Received an injection of a long-term contraceptive hormone (such as depot-medroxyprogesterone acetate) within 6 months of study entry or intends to receive one within 1 year of study entry
* Intends to use Lunelle, the vaginal contraceptive ring, or the contraceptive patch for contraception within 1 year of study entry
* Intends to use partners' vasectomy as her method of contraception within 1 year of study entry
* Pregnant or breastfeeding
* Known or suspected infertility
* Previously participated in this study
* Planning to move out of the study area within 1 year of study entry
* Currently participating in another research study that would interfere with the conduct of this study
B: Inclusion Criteria:

* All women who delivers in the obstetric intent to breast-feed.
* Eligible participants should have been planning of birth spacing

Exclusion Criteria:

* Women refusal to participate in the study
* Women planned to use a method of contraception other than LAM
* Anticipation of difficulty of subsequent communication with the woman
C: Inclusion Criteria:

* Menstruating women at least 18 years old;
* Give voluntary, written informed consent, and agree to observe all study requirements;
* Request emergency contraception within 72 hours (3 days) after unprotected coitus, as defined by lack of contraceptive use, or condom breakage (including condoms lubricated with spermicide) or other barrier contraceptive method failure;
* Reports that all acts of unprotected coitus during the current cycle are within 72 hours prior to enrollment;
* Willing to abstain from further acts of unprotected intercourse during that cycle;
* History of regular menstrual cycles (mean length of 24-42 days with intra-individual variation of ±5 days);
* At least one normal menstrual cycle (2 menses) post delivery or abortion;
* If subject recently discontinued hormonal contraception, one normal menstrual cycle (2 menses) must have been completed before entry in the study
* For women with a recent history of Depo Provera use, the most recent injection must be at least 3 months before study entry and the subject must have had at least one normal menstrual cycle (2 menses);
* Available for follow-up for at least the next four weeks.

Exclusion Criteria:

* Currently pregnant (positive high-sensitivity urine pregnancy test);
* pregnant or breast-feeding within the past two months;
* use of hormonal methods of contraception during the current or previous two cycles;
* current user of IUD;
* tubal ligation;
* partners with history of vasectomy;
* unsure about the date of the last menstrual period (+3 days);
* irregular menstrual cycles as defined in the inclusion criteria;
* nausea and vomiting within the previous two weeks;
* impaired hypothalamic-pituitary-adrenal reserve or oral glucocorticoid replacement therapy in the last year.

Subjects cannot be currently enrolled in any other investigational trial or re-enrolled in this study.
D: Inclusion Criteria:1. Between 18-35 years old

2. In need of EC (had unprotected intercourse within 120 hours - 5 days)

3. Desire to prevent pregnancy for 1 year

4. Fluent in English and/or Spanish

5. Have a regular menstrual cycle (24-35 days)

6. Know their last menstrual period (+/-3 days)

7. Be willing to comply with the study requirements

8. Participants current preferred phone number must be functioning at the time of study entry and will be tested prior to enrollment

-

Exclusion Criteria:

* 1. Current pregnancy

  2. Breastfeeding

  3. Intrauterine infection within the past 3 months

  4. Sterilization

  5. Already have an IUD or contraceptive implant (Implanon) in place

  6. Vaginal bleeding of unknown etiology

  7. Known Gonorrhea or Chlamydia infection in the last 30 days (unless successfully treated at least 7 days prior to study entry)

  8. Allergy to LNG (for LNG IUD patients)

  9. Allergy to copper or Wilson's disease (for Copper IUD patients)

  10. Known abnormalities of the uterus that distort the uterine cavity

Answer: A